TPO and thyrotoxicosis: This category of medications primarily inhibits the synthesis of thyroid hormones by predominantly targeting thyroid peroxidase in hyperactive thyroid tissues.[25] This mechanism diminishes T3 and T4 levels, thereby ameliorating the unfavorable prognosis of thyrotoxicosis and associated heart failure.